Catalyst Event
Cogent Biosciences Inc (COGT) · Other
From KEDI U.S. Next Tech TOP10 Index (KUNTT10)
5/28/2026, 12:00:00 AM
Announced on May 28, 2026, that the U.S. FDA accepted its NDA for bezuclastinib for GIST with Priority Review, setting a PDUFA date of November 30, 2026. High importance estimated due to critical regulatory milestone.
Korean Translation
2026년 5월 28일 FDA의 위장관 기질 종양(GIST) 치료제 베주클라스티닙 NDA 우선 심사 승인 및 2026년 11월 30일 PDUFA 목표일 지정을 발표함. 핵심적인 규제 단계 통과로 높은 중요도가 예상됨.
Related Recent Events
AST SpaceMobile Inc (ASTS) · Earnings Release
Q2 2026 earnings release and conference call for August 10, 2026, which is expected to have a medium impact by providing key financial updates, scheduled.
8/10/2026, 12:00:00 AM
D-Wave Quantum Inc (QBTS) · Earnings Release
Next quarterly earnings report for Q2 2026 is scheduled for 2026-08-06; scheduled.
8/6/2026, 12:00:00 AM
Cogent Biosciences Inc (COGT) · Earnings Release
Q2 2026 earnings release on August 4, 2026; low importance estimated as scheduled earnings announcement expected.
8/4/2026, 12:00:00 AM
AeroVironment Inc (AVAV) · Earnings Release
AeroVironment is expected to release its Q4 and full fiscal year 2026 earnings results on or around June 29, 2026; high impact is estimated due to previous Q3 contract termination and impairment expected
6/29/2026, 12:00:00 AM
AST SpaceMobile Inc (ASTS) · Other
Launch of three BlueBird satellites (8, 9, and 10) via a SpaceX Falcon 9 rocket on June 15, 2026, which is expected to have a medium impact as a significant deployment milestone, scheduled.
6/15/2026, 12:00:00 AM
Cloudflare Inc (NET) · Other
Cloudflare is scheduled to host its 2026 Investor Day at the New York Stock Exchange to provide updates on strategy and financials. This event is estimated to have a 5% price impact as strategic roadmaps are revealed, scheduled.
6/9/2026, 12:00:00 AM